These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 669876)

  • 21. Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.
    Ravis WR; Pedersoli WM; Turco JD
    Am J Vet Res; 1987 Aug; 48(8):1244-9. PubMed ID: 3631715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on pharmacokinetics of digoxin in hyperthyroid and hypothyroid dogs].
    Wakamatsu Y; Ogawa K
    Jpn Circ J; 1982 Nov; 46 Suppl 3():501-9. PubMed ID: 7131718
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-independent pharmacokinetics of digoxin in humans.
    Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
    Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum digoxin in patients with thyroid disease.
    Croxson MS; Ibbertson HK
    Br Med J; 1975 Sep; 3(5983):566-8. PubMed ID: 1100180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of indomethacin on digoxin pharmacokinetics in preterm infants.
    Koren G; Zarfin Y; Perlman M; MacLeod SM
    Pediatr Pharmacol (New York); 1984; 4(1):25-30. PubMed ID: 6739184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and clinical effects of atenolol in therapy of hyperthyroidism.
    Geffner DL; Sladek J; Hershman JM
    Drugs Exp Clin Res; 1990; 16(4):167-73. PubMed ID: 2076652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of temperature on the kinetics of propranolol, theophylline, phenytoin and digoxin in rats (author's transl)].
    Albin H; Vincon G; Ploux D; Dangoumau J
    J Pharmacol; 1981; 12(3):229-38. PubMed ID: 7289622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No enhanced elimination of propranolol in patients with hyperthyroidism.
    Ishizaki T; Masuno M; Tawara K
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite.
    Butler VP; Tse-Eng D; Lindenbraum J; Kalman SM; Preibisz JJ; Rund DG; Wissel PS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):123-31. PubMed ID: 7062278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spironolactone-induced changes in digoxin kinetics.
    Waldorff S; Andersen JD; Heebøll-Nielsen N; Nielsen OG; Moltke E; Sørensen U; Steiness E
    Clin Pharmacol Ther; 1978 Aug; 24(2):162-7. PubMed ID: 679595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin kinetics in patients with thyroid dysfunction.
    Lawrence JR; Sumner DJ; Kalk WJ; Ratcliffe WA; Whiting B; Gray K; Lindsay M
    Clin Pharmacol Ther; 1977 Jul; 22(1):7-13. PubMed ID: 872497
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of quinine on digoxin kinetics.
    Wandell M; Powell JR; Hager WD; Fenster PE; Graves PE; Conrad KA; Goldman S
    Clin Pharmacol Ther; 1980 Oct; 28(4):425-30. PubMed ID: 7408402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease.
    Doherty JE; Perkins WH
    Ann Intern Med; 1966 Mar; 64(3):489-507. PubMed ID: 4159745
    [No Abstract]   [Full Text] [Related]  

  • 37. Biotransformation and elimination of digoxin with normal and minimal renal function.
    Gault MH; Sugden D; Maloney C; Ahmed M; Tweeddale M
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):499-513. PubMed ID: 436354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of digoxin in newborn and adult sheep.
    Berman W; Musselman J; Shortencarrier R
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):173-86. PubMed ID: 7120047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption of digoxin from different oral preparations in normal subjects during steady state.
    Huffman DH; Manion CV; Azarnoff DL
    Clin Pharmacol Ther; 1974 Aug; 16(2):310-7. PubMed ID: 4850376
    [No Abstract]   [Full Text] [Related]  

  • 40. Absolute bioavailability of digoxin in chronic renal failure.
    Ohnhaus EE; Vozeh S; Nüesch E
    Clin Nephrol; 1979 Jun; 11(6):302-6. PubMed ID: 477047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.